Peptide Injections AI
Pe-22-28 peptide therapy
Cognitive EnhancementAnecdotal

Pe-22-28 Peptide Therapy

Benefits, Side Effects, Cost & Protocols

PE-22-28 is a synthetic peptide derived from the phosphodiesterase-4 (PDE4) inhibitor family that has been studied for nootropic and neuroprotective effects. It modulates cAMP signaling in the brain to potentially enhance memory consolidation and cognitive function.

ByChris Riley(CFA)&Alex Evans, PharmD, MBA(PharmD, MBA)|Updated

Clinically Reviewed

Reviewed by Alex Evans, PharmD, MBA · Updated May 2026

Evidence-Based

Sourced from FDA, PubMed & ClinicalTrials.gov · View sources

FDA Status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Anecdotal
Category
Cognitive Enhancement

How Pe-22-28 Works

Spadin analog that may modulate TREK-1 potassium channels, potentially offering rapid antidepressant-like effects.

Pe-22-28 FAQ

What is PE-22-28?

PE-22-28 is a synthetic peptide analog of Spadin, researched for its potential antidepressant and cognitive-enhancing effects.

How does PE-22-28 work?

Spadin analog that may modulate TREK-1 potassium channels, potentially offering rapid antidepressant-like effects.

Is PE-22-28 legal to buy?

PE-22-28 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy PE-22-28?

PE-22-28 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does PE-22-28 belong to?

PE-22-28 is primarily classified as a cognitive enhancement peptide. Nootropic peptides researched for cognitive function, memory, focus, neuroprotection, and neurogenesis.

What are the research benefits of PE-22-28?

PE-22-28 has been studied for: Antidepressant research, Mood support, Cognitive enhancement. Spadin analog; mood and cognition research.

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapies have not been evaluated by the FDA for most listed indications.All prices shown are estimates based on publicly available data and may not reflect current pricing — providers and brands set their own prices and can change them at any time. Always verify pricing directly with the provider before purchasing. Consult a licensed healthcare provider before starting any peptide protocol.

Ready to explore Pe-22-28 with a provider?

Take our 2-minute quiz to get matched with a board-certified provider specializing in Pe-22-28.

Take the Quiz →